119 related articles for article (PubMed ID: 25765988)
1. Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma.
Duconseil P; Gilabert M; Gayet O; Loncle C; Moutardier V; Turrini O; Calvo E; Ewald J; Giovannini M; Gasmi M; Bories E; Barthet M; Ouaissi M; Goncalves A; Poizat F; Raoul JL; Secq V; Garcia S; Viens P; Iovanna J; Dusetti N
Am J Pathol; 2015 Apr; 185(4):1022-32. PubMed ID: 25765988
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer.
Nicolle R; Blum Y; Duconseil P; Vanbrugghe C; Brandone N; Poizat F; Roques J; Bigonnet M; Gayet O; Rubis M; Elarouci N; Armenoult L; Ayadi M; de Reyniès A; Giovannini M; Grandval P; Garcia S; Canivet C; Cros J; Bournet B; Buscail L; ; Moutardier V; Gilabert M; Iovanna J; Dusetti N
EBioMedicine; 2020 Jul; 57():102858. PubMed ID: 32629389
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance.
Kaoutari AE; Fraunhoffer NA; Hoare O; Teyssedou C; Soubeyran P; Gayet O; Roques J; Lomberk G; Urrutia R; Dusetti N; Iovanna J
EBioMedicine; 2021 Apr; 66():103332. PubMed ID: 33862584
[TBL] [Abstract][Full Text] [Related]
4. A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor.
Gayet O; Loncle C; Duconseil P; Gilabert M; Lopez MB; Moutardier V; Turrini O; Calvo E; Ewald J; Giovannini M; Gasmi M; Bories E; Barthet M; Ouaissi M; Goncalves A; Poizat F; Raoul JL; Secq V; Garcia S; Viens P; Dusetti N; Iovanna J
Oncotarget; 2015 Jan; 6(2):746-54. PubMed ID: 25481873
[TBL] [Abstract][Full Text] [Related]
5. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
6. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
7. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
8. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
9. Speeding towards individualized treatment for pancreatic cancer by taking an alternative road.
Iovanna J; Dusetti N
Cancer Lett; 2017 Dec; 410():63-67. PubMed ID: 28947138
[TBL] [Abstract][Full Text] [Related]
10. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer.
Yu KH; Ricigliano M; Hidalgo M; Abou-Alfa GK; Lowery MA; Saltz LB; Crotty JF; Gary K; Cooper B; Lapidus R; Sadowska M; O'Reilly EM
Clin Cancer Res; 2014 Oct; 20(20):5281-9. PubMed ID: 25107917
[TBL] [Abstract][Full Text] [Related]
12. [Organoids from pancreatic ductal adenocarcinoma].
Dusetti N; Iovanna J
Med Sci (Paris); 2020 Jan; 36(1):57-62. PubMed ID: 32014099
[TBL] [Abstract][Full Text] [Related]
13. Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma.
Samuel N; Sayad A; Wilson G; Lemire M; Brown KR; Muthuswamy L; Hudson TJ; Moffat J
Pancreas; 2013 Aug; 42(6):1016-26. PubMed ID: 23851435
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.
Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M
Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497
[TBL] [Abstract][Full Text] [Related]
15. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
16. Invasive markers identified by gene expression profiling in pancreatic cancer.
Rogers A; Smith MJ; Doolan P; Clarke C; Clynes M; Murphy JF; McDermott A; Swan N; Crotty P; Ridgway PF; Conlon KC
Pancreatology; 2012; 12(2):130-40. PubMed ID: 22487523
[TBL] [Abstract][Full Text] [Related]
17. [Selection of genes related to multidrug resistance of pancreatic ductal adenocarcinoma by microarray analysis].
Feng B; Zhao YP; Chen G; Zhang TP; Wu YD
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(23):1629-33. PubMed ID: 18453221
[TBL] [Abstract][Full Text] [Related]
18. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.
Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393
[TBL] [Abstract][Full Text] [Related]
19. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.
Kim KT; Lee HW; Lee HO; Kim SC; Seo YJ; Chung W; Eum HH; Nam DH; Kim J; Joo KM; Park WY
Genome Biol; 2015 Jun; 16(1):127. PubMed ID: 26084335
[TBL] [Abstract][Full Text] [Related]
20. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.
Steele CW; Oien KA; McKay CJ; Jamieson NB
Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
